17-Apr-2026
No headlines found.
No press releases found.
No news found.
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer discretionary, that are relevant to the Fund's investment theme of the genomics revolution. Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. The companies held in ARKG may be leaders, enablers, or beneficiaries of technologies.
Ark Genomic Revolution ETF trades on the ARCA stock market under the symbol ARKG.
As of April 17, 2026, ARKG stock price climbed to $30.79 with 3,803,326 million shares trading.
ARKG has a beta of 1.63, meaning it tends to be more sensitive to market movements. ARKG has a correlation of 0.35 to the broad based SPY ETF.
ARKG has a market cap of $1.20 billion. This is considered a Small Cap stock.
In the last 3 years, ARKG traded as high as $38.97 and as low as $17.51.
ARKG has outperformed the market in the last year with a price return of +49.0% while the SPY ETF gained +36.3%. However, in the short term, ARKG had mixed performance relative to the market. It has underperformed in the last 3 months, returning -3.2% vs +2.9% return in SPY. But in the last 2 weeks, ARKG shares have fared better than the market returning +12.5% compared to SPY +8.3%.
ARKG support price is $28.89 and resistance is $30.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARKG shares will trade within this expected range on the day.
